The global aesthetic dermatology market is projected to register a substantial CAGR of 10.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029.
Market Segmentation:
Global Aesthetic Dermatology Market, By Product Type (Medicines and Devices), Surgery Type (Minimally Invasive and Non-Invasive), Treatment Type (Face Treatment and Body Treatment), Application (Skin Rejuvenation, Skin Resurfacing, Skin Tightening, Hair Removal, Pigmented & Vascular Lesions, Tattoo Removal, Scar, Acne, Dyschromia, Skin Tags, Psoriasis, Warts, Hyperhidrosis, Moles and Freckles and Others), Gender (Female and Male), End User (Hospitals, Dermatology Clinics, Surgical Centers, Spa Clinics and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippine, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) - Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of global aesthetic dermatology market are:
- Increasing urge to improve one's appearance
- Growing technological advancements
- Increase in demand of aesthetic appearance
Market Players:
The major companies which are dealing in the global aesthetic dermatology market are listed below:
- AbbVie Inc.
- Henry Schein, Inc.
- Merz Pharma, Cutera
- Cynosure. Inc. (A Subsidiary of Hologic, Inc.)
- Candela Medical, Bausch Health Companies Inc.
- Evolus, Inc.
- Medytox
- LUTRONIC
- HUGEL, Inc.
- El. En. S.p.A.
- Hoahai
- REVANCE THERAPEUTICS
- Lumenis Be Ltd.
- Venus Concept
- Alma Lasers
- Fotona
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 OBJECTIVES OF THE STUDY
- 1.2 MARKET DEFINITION
- 1.3 OVERVIEW OF GLOBAL AESTHETIC DEVICE MARKET
- 1.4 LIMITATIONS
- 1.5 MARKETS COVERED
2 MARKET SEGMENTATION
- 2.1 MARKETS COVERED
- 2.2 GEOGRAPHICAL SCOPE
- 2.3 YEARS CONSIDERED FOR THE STUDY
- 2.4 CURRENCY AND PRICING
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL
- 2.6 MULTIVARIATE MODELLING
- 2.7 PRODUCT LIFELINE CURVE
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
- 2.9 DBMR MARKET POSITION GRID
- 2.10 MARKET APPLICATION COVERAGE GRID
- 2.11 VENDOR SHARE ANALYSIS
- 2.12 SECONDARY SOURCES
- 2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
- 3.1 PESTEL'S MODEL
- 3.2 PORTER'S FIVE FORCES MODEL
4 GLOBAL AESTHETIC DEVICES MARKET: REGULATIONS
- 4.1 REGULATION OF COSMETIC-RELATED MEDICAL DEVICES
5 MARKET OVERVIEW
- 5.1 DRIVERS
- 5.1.1 RISING PREVALENCE OF MINIMALLY INVASIVE PROCEDURES
- 5.1.2 INCREASING GERIATRIC POPULATION
- 5.1.3 TECHNOLOGICAL ADVANCEMENTS IN AESTHETIC DEVICES
- 5.1.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
- 5.2 RESTRAINTS
- 5.2.1 HIGH COST OF AESTHETIC SURGICAL PROCEDURES
- 5.2.2 SIDE EFFECTS RELATED TO AESTHETIC ENERGY BASED DEVICES
- 5.3 OPPORTUNITIES
- 5.3.1 INCREASING HEALTHCARE EXPENDITURE
- 5.3.2 INCREASING FUNDING ACTIVITIES FOR AESTHETIC RESEARCH
- 5.3.3 INCREASING AWARENESS TOWARDS AESTHETIC SURGERIES
- 5.3.4 INCREASING RESEARCH AND DEVELOPMENT
- 5.4 CHALLENGES
- 5.4.1 LACK OF SKILLED PROFESSIONALS
- 5.4.2 AVAILABILITY OF ALTERNATIVES
6 GLOBAL AESTHETIC DEVICES MARKET, BY PRODUCTS
- 6.1 OVERVIEW
- 6.2 FACIAL AESTHETICS PRODUCTS
- 6.2.1 BOTULINUM TOXIC
- 6.2.2 DERMAL FILLERS
- 6.2.3 MICRODERMABRASION
- 6.2.4 CHEMICAL PEELS
- 6.3 BODY CONTOURING DEVICES
- 6.3.1 LIPOSUCTION DEVICES
- 6.3.2 CELLULITE REDUCTION DEVICES
- 6.3.3 NON-SURGICAL FAT REDUCTION DEVICES
- 6.4 COSMETIC IMPLANTS
- 6.4.1 BREAST IMPLANTS
- 6.4.2 DENTAL IMPLANTS
- 6.4.3 IMPLANTS FOR THE BODY
- 6.4.4 CUSTOM MADE IMPLANTS
- 6.5 SKIN AESTHETIC DEVICES
- 6.5.1 NON-SURGICAL SKIN TIGHTENING DEVICES
- 6.5.2 LASER RESURFACING DEVICES
- 6.5.3 LIGHT THERAPY DEVICES
- 6.5.4 MICRO-NEEDLING PRODUCTS
- 6.6 HAIR REMOVAL DEVICES
- 6.6.1 LASER HAIR REMOVAL DEVICES
- 6.6.2 IPL HAIR REMOVAL DEVICES
- 6.7 OTHERS
- 6.7.1 PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS
- 6.7.2 PHYSICIAN-DISPENSED EYELASH PRODUCTS
- 6.7.3 THREAD LIFT PRODUCTS
- 6.7.4 TATTOO REMOVAL DEVICES
- 6.7.5 NAIL TREATMENT LASER DEVICES
7 GLOBAL AESTHETIC DEVICES MARKET, BY RAW MATERIALS
- 7.1 OVERVIEW
- 7.2 POLYMERS
- 7.3 BIOMATERIALS
- 7.4 METALS
8 GLOBAL AESTHETIC DEVICES MARKET, BY END USER
- 8.1 OVERVIEW
- 8.2 HOSPITALS
- 8.3 DERMATOLOGY CLINICS
- 8.4 CLINICS
- 8.5 ACADEMIC AND PRIVATE RESEARCH INSTITUTES
- 8.6 OTHERS
- 8.6.1 COSMETIC CENTERS
- 8.6.2 HOMECARE
- 8.6.3 MEDICAL SPAS AND BEAUTY CENTERS
9 GLOBAL AESTHETIC DEVICES MARKET, BY DISTRIBUTION CHANNEL
- 9.1 OVERVIEW
- 9.2 DIRECT TENDER
- 9.3 RETAIL SALES
10 GLOBAL AESTHETIC DEVICES MARKET, BY REGION
- 10.1 OVERVIEW
- 10.2 NORTH AMERICA
- 10.2.1 U.S.
- 10.2.2 CANADA
- 10.2.3 MEXICO
- 10.3 EUROPE
- 10.3.1 GERMANY
- 10.3.2 FRANCE
- 10.3.3 U.K.
- 10.3.4 ITALY
- 10.3.5 RUSSIA
- 10.3.6 SPAIN
- 10.3.7 TURKEY
- 10.3.8 NETHERLANDS
- 10.3.9 SWITZERLAND
- 10.3.10 BELGIUM
- 10.3.11 REST OF EUROPE
- 10.4 ASIA-PACIFIC
- 10.4.1 CHINA
- 10.4.2 JAPAN
- 10.4.3 INDIA
- 10.4.4 SOUTH KOREA
- 10.4.5 AUSTRALIA
- 10.4.6 THAILAND
- 10.4.7 MALAYSIA
- 10.4.8 SINGAPORE
- 10.4.9 INDONESIA
- 10.4.10 PHILIPPINES
- 10.4.11 REST OF ASIA-PACIFIC
- 10.5 SOUTH AMERICA
- 10.5.1 BRAZIL
- 10.5.2 ARGENTINA
- 10.5.3 REST OF SOUTH AMERICA
- 10.6 MIDDLE EAST & AFRICA
- 10.6.1 SOUTH AFRICA
- 10.6.2 SAUDI ARABIA
- 10.6.3 U.A.E.
- 10.6.4 EGYPT
- 10.6.5 ISRAEL
- 10.6.6 REST OF MIDDLE EAST & AFRICA
11 GLOBAL AESTHETIC DEVICES MARKET: COMPANY LANDSCAPE
- 11.1 COMPANY SHARE ANALYSIS: GLOBAL
- 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
- 11.3 COMPANY SHARE ANALYSIS: EUROPE
- 11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 SWOT ANALYSIS
13 COMPANY PROFILE
- 13.1 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.)
- 13.1.1 COMPANY SNAPSHOT
- 13.1.2 COMPANY SHARE ANALYSIS
- 13.1.3 PRODUCT PORTFOLIO
- 13.1.4 RECENT DEVELOPMENTS
- 13.2 MENTOR WORLDWIDE LLC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
- 13.2.1 COMPANY SNAPSHOT
- 13.2.2 COMPANY SHARE ANALYSIS
- 13.2.3 PRODUCT PORTFOLIO
- 13.2.4 RECENT DEVELOPMENT
- 13.3 SHANGHAI FOSUN PHARMACUETICAL (GROUP) CO,LTD
- 13.3.1 COMPANY SNAPSHOT
- 13.3.2 REVENUE ANALYSIS
- 13.3.3 COMPANY SHARE ANALYSIS
- 13.3.4 PRODUCT PORTFOLIO
- 13.3.5 RECENT DEVELOPMENT
- 13.4 BAUSCH HEALTH COMPANIES INC.
- 13.4.1 COMPANY SNAPSHOT
- 13.4.2 REVENUE ANALYSIS
- 13.4.3 COMPANY SHARE ANALYSIS
- 13.4.4 PRODUCT PORTFOLIO
- 13.4.5 RECENT DEVELOPMENT
- 13.5 CANDELA MEDICAL
- 13.5.1 COMPANY SNAPSHOT
- 13.5.2 COMPANY SHARE ANALYSIS
- 13.5.3 PRODUCT PORTFOLIO
- 13.5.4 RECENT DEVELOPMENT
- 13.6 CUTERA
- 13.6.1 COMPANY SNAPSHOT
- 13.6.2 REVENUE ANALYSIS
- 13.6.3 PRODUCT PORTFOLIO
- 13.6.4 RECENT DEVELOPMENTS
- 13.7 CYNOSURE (A SUBSIDIARY OF HOLOGIC INC.)
- 13.7.1 COMPANY SNAPSHOT
- 13.7.2 PRODUCT PORTFOLIO
- 13.7.3 RECENT DEVELOPMENT
- 13.8 LUTRONIC INC.
- 13.8.1 COMPANY SNAPSHOT
- 13.8.2 PRODUCT PORTFOLIO
- 13.8.3 RECENT DEVELOPMENTS
- 13.9 AEROLASE CORP.
- 13.9.1 COMPANY SNAPSHOT
- 13.9.2 PRODUCT PORTFOLIO
- 13.9.3 RECENT DEVELOPMENTS
- 13.10 AIRXPANDERS, INC.
- 13.10.1 COMPANY SNAPSHOT
- 13.10.2 PRODUCT PORTFOLIO
- 13.10.3 RECENT DEVELOPMENT
- 13.11 BTL.
- 13.11.1 COMPANY SNAPSHOT
- 13.11.2 PRODUCT PORTFOLIO
- 13.11.3 RECENT DEVELOPMENT
- 13.12 GC AESTHETICS
- 13.12.1 COMPANY SNAPSHOT
- 13.12.2 PRODUCT PORTFOLIO
- 13.12.3 RECENT DEVELOPMENT
- 13.13 LUMENIS
- 13.13.1 COMPANY SNAPSHOT
- 13.13.2 PRODUCT PORTFOLIO
- 13.13.3 RECENT DEVELOPMENT
- 13.14 MEDYTROX
- 13.14.1 COMPANY SNAPSHOT
- 13.14.2 PRODUCT PORTFOLIO
- 13.14.3 RECENT DEVELOPMENT
- 13.15 MERZ NORTH AMERICA, INC.
- 13.15.1 COMPANY SNAPSHOT
- 13.15.2 PRODUCT PORTFOLIO
- 13.15.3 RECENT DEVELOPMENTS
- 13.16 QUANTA SYSTEM
- 13.16.1 COMPANY SNAPSHOT
- 13.16.2 PRODUCT PORTFOLIO
- 13.16.3 RECENT DEVELOPMENT
- 13.17 SHARPLIGHT TECHNOLOGIES LLC
- 13.17.1 COMPANY SNAPSHOT
- 13.17.2 PRODUCT PORTFOLIO
- 13.17.3 RECENT DEVELOPMENT
- 13.18 SIENTRA, INC.
- 13.18.1 COMPANY SNAPSHOT
- 13.18.2 REVENUE ANALYSIS
- 13.18.3 PRODUCT PORTFOLIO
- 13.18.4 RECENT DEVELOPMENT
- 13.19 SUNEVA MEDICAL
- 13.19.1 COMPANY SNAPSHOT
- 13.19.2 PRODUCT PORTFOLIO
- 13.19.3 RECENT DEVELOPMENT
- 13.20 VENUS CONCEPT
- 13.20.1 COMPANY SNAPSHOT
- 13.20.2 REVENUE ANALYSIS
- 13.20.3 PRODUCT PORTFOLIO
- 13.20.4 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS